|
1
|
Guzauskas GF, Wang BCM, Pollom EL, Stieber VW, Kinzel A, Proescholdt C, Garrison L. P01.102 Cost effectiveness of treating glioblastoma patients age 65 years or older with Tumor Treating Fields plus Temozolomide versus Temozolomide alone. Neuro Oncol 2018. [DOI: 10.1093/neuonc/noy139.144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- G F Guzauskas
- University of Washington Department of Pharmacy, Seattle, WA, United States
| | - B C M Wang
- University of Washington Department of Pharmacy, Seattle, WA, United States
| | - E L Pollom
- Stanford University, Department of Radiation Oncology, Stanford, CA, United States
| | - V W Stieber
- Novant Health Forsyth Medical Center, Winston Salem, NC, United States
| | | | | | - L Garrison
- University of Washington Department of Pharmacy, Seattle, WA, United States
| |
Collapse
|
|
2
|
Guzauskas GF, Wang BCM, Kinzel A, Proescholdt C. P01.110 Elderly patients >65years of age with newly diagnosed Glioblastoma multiforme gain life time from treatment with Tumor Treating Fields and Temozolomide. Neuro Oncol 2018. [DOI: 10.1093/neuonc/noy139.152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- G F Guzauskas
- University of Washington Department of Pharmacy, Seattle, WA, United States
| | - B C M Wang
- University of Washington Department of Pharmacy, Seattle, WA, United States
| | | | | |
Collapse
|
|
3
|
Guzauskas GF, Wang BCM, Kinzel A, Proescholdt C. P01.109 Tumor treating fields treatment for patients with newly diagnosed glioblastoma: a cost-effectiveness analysis for Sweden. Neuro Oncol 2018. [DOI: 10.1093/neuonc/noy139.151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- G F Guzauskas
- University of Washington Department of Pharmacy, Seattle, WA, United States
| | - B C M Wang
- University of Washington Department of Pharmacy, Seattle, WA, United States
| | | | | |
Collapse
|
|
4
|
Tang CH, Wang BCM, Furnback WE, Ney JP, Yang YW, Fang CH, Hsu PN. Estimating Health Care Resource Utilization of Patients with Rheumatoid Arthritis in Taiwan Using a National Claims Database. Value Health 2014; 17:A774. [PMID: 27202861 DOI: 10.1016/j.jval.2014.08.335] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- C H Tang
- Taipei Medical University, Taipei, Taiwan
| | - B C M Wang
- Alliance Life Sciences, Somerset, NJ, USA
| | | | - J P Ney
- University of Washington, Seattle, WA, USA
| | - Y W Yang
- Pfizer Limited, New Taipei City, Taiwan
| | | | - P N Hsu
- National Taiwan University, Taipei, Taiwan
| |
Collapse
|
|
5
|
Wang BCM, Xie XP, Furnback W. Estimating The Impact Of Expanding Access To Celecoxib For Osteoarthritis Patients In China. Value Health 2014; 17:A772. [PMID: 27202848 DOI: 10.1016/j.jval.2014.08.324] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- B C M Wang
- Alliance Life Sciences, Somerset, NJ, USA
| | | | - W Furnback
- Alliance Life Sciences, Somerset, NJ, USA
| |
Collapse
|
|
6
|
Furnback W, Wang BCM. Using The Ispor 2013 European Congress as a Big Data Case Study. Value Health 2014; 17:A433. [PMID: 27201136 DOI: 10.1016/j.jval.2014.08.1107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- W Furnback
- Alliance Life Sciences, Somerset, NJ, USA
| | - B C M Wang
- Alliance Life Sciences, Somerset, NJ, USA
| |
Collapse
|
|
7
|
Furnback W, Wang BCM. Assesing the Impact of Patent Loss on Overall Revenues and Stocks Price of Pharmaceutical Companies. Value Health 2014; 17:A785. [PMID: 27202920 DOI: 10.1016/j.jval.2014.08.404] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- W Furnback
- Alliance Life Sciences, Somerset, NJ, USA
| | - B C M Wang
- Alliance Life Sciences, Somerset, NJ, USA
| |
Collapse
|
|
8
|
Wang BCM, Furnback WE, Ney JP, Garrison LP, Fang C. THU0511 Estimating the Burden of Illness of Fibromyalgia in Taiwan. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.1039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|